Fundraising Fox

Pasithea Therapeutics

NASDAQ: KTTA

Venice, US · Founded 2020 · Delaware corporation · 1 known investors

pasithea.com

Founders & leadership

LS
Lawrence SteinmanDirector
TR
Tiago Reis MarquesDirector
IM
Israel Maxx AbramowitzExecutive Officer, Director
CA
Craig AuringerExecutive Officer, Director

Investors · 1

Reported raises · per SEC filings

Form D private placements
$30.4MraisedDec 2021 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence SteinmanDirector
  • Simon DumesnilDirector
  • Stanley M. GlossExecutive Officer
  • Emer LeahyDirector
  • Tiago Andre Dos Reis MarquesExecutive Officer, Director
  • Yassine BendiabdallahExecutive Officer, Director
Offering amount
$30.4M
Amount sold
$30.4M
Sales commissions
$2.7M
Placement agents
EF Hutton, division of Benchmark Investments, LLC
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.2MraisedMar 2021 · 30 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence SteinmanDirector
  • Tiago Reis MarquesDirector
  • Israel Maxx AbramowitzExecutive Officer, Director
  • Craig AuringerExecutive Officer, Director
Offering amount
$5M
Amount sold
$1.2M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$250KraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence SteinmanDirector
  • Tiago Reis MarquesDirector
  • Israel Maxx AbramowitzExecutive Officer, Director
  • Craig AuringerExecutive Officer, Director
Offering amount
$1M
Amount sold
$250K
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.